What is HTFL's market cap?

$4.92B, based on the Nov 4 close of $56.57.

Does Heartflow pay a dividend?

No regular cash dividend has been paid in the last year.

How much of HTFL is sold short?

7.3M shares, 10.6% of float, as of Oct 15, 2026.

What sector is HTFL in?

Healthcare, in the Surgical Instruments industry.

NASDAQ · HTFLHealthcareSurgical Instruments

Heartflow, Inc. Common Stock (HTFL)

$56.57+3.99%

Close Nov 4, 2026 · split-adjusted

Nov 2, 2026$54.49▲ 60.05% in range

Nov 3, 2025Low $20.49 · High $60.53Nov 2, 2026

What changed · written from our data

As of Nov 4, 2026

Heartflow closed at $56.57 on Nov 4, up 3.99%, 6.5% below its 52-week closing high. Volume of 1.6M shares was 1.01× its 20-day average (close to normal).

Split-adjusted performance: +11.6% over one month, +86.8% over six months, +66.2% over one year.

In the quarter ended Jun 30, 2026, revenue was $64.08M, with a net margin of -24.6%.

Short interest was 7.3M shares at the Oct 15 settlement, up 7.5% from the prior report (10.6% of float, 4.4 days to cover).

Market cap$4.92B87.0M shares

Revenue · quarter$64.1M—

Diluted EPS$-0.18—

P/E · TTM—P/S 23.2×

Net margin-24.6%Gross 83.0%

Dividend yieldNone

52-week range20.49 – 60.53−6.5% from high

Volume1.6M1.01× 20-day avg

Volatility · 60d79.9%Annualised

Short % of float10.6%4.4 days to cover

Net cash$162.6MCash $162.6M

Next earnings—Not scheduled

Split-adjusted performance

1W −4.3%1M +11.6%3M +108.1%6M +86.8%YTD +94.1%1Y +66.2%3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum91

Revenue growth—

Net margin40

Value (low P/E)—

Size84

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →

Shares short7.3M+7.5% vs prior

Days to cover4.4Settled Oct 15

% of float10.6%

Short vol. 10d43.7%of daily volume

Closest peers by size in Surgical Instruments

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
HTFLHeartflow	$56.57	+3.99%	+86.8%	—	−24.6%	—	$4.92B
MMEDMiniMed Group	$19.29	+2.33%	—	—	0.0%	—	$5.43B	Compare
MMSIMerit Medical Systems	$90.63	+7.69%	+47.1%	+8.4%	10.2%	33.9	$5.43B	Compare
IRTCiRhythm Holdings	$134.00	+6.04%	+13.8%	+20.1%	−0.2%	—	$4.42B	Compare
ICUIICU Medical	$172.62	+6.67%	+44.3%	+0.5%	3.5%	143.5	$4.32B	Compare
HAEHaemonetics	$127.42	+5.94%	+141.9%	+5.6%	9.7%	60.2	$5.80B	Compare
PLSEPulse Biosciences, Inc Common Stock (DE)	$57.06	+9.31%	+197.0%	—	−5681.3%	—	$4.07B	Compare
TFXTeleflex Incorporated	$149.87	+7.09%	+21.6%	+28.9%	17.5%	—	$6.35B	Compare
ATRCAtriCure	$65.53	+8.48%	+134.0%	+12.8%	5.8%	315.9	$3.33B	Compare

News about Heartflow

All news →

TCT 2026: CT-guided PCI Matches IVUS Outcomes in Randomized P4 Trial; Heartflow PCI Navigator Changes PCI Plans in Approximately 70% of PatientsGlobeNewswire Inc. · 3d ago▲ Positive Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly HalfGlobeNewswire Inc. · Aug 28, 2026▲ Positive Why Heartflow Stock Soared TodayThe Motley Fool · Aug 14, 2026▲ Positive What Does the HeartFlow CEO's Sale of Over 20,000 Company Shares Mean for Investors?The Motley Fool · Jul 15, 2026▲ Positive Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026?The Motley Fool · Jul 8, 2026Neutral

Quick answers

What does Heartflow do?: HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions.
What is HTFL's market cap?: $4.92B, based on the Nov 4 close of $56.57.
Does Heartflow pay a dividend?: No regular cash dividend has been paid in the last year.
How much of HTFL is sold short?: 7.3M shares, 10.6% of float, as of Oct 15, 2026.
What sector is HTFL in?: Healthcare, in the Surgical Instruments industry.

About Heartflow

HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.

HQ: San Francisco, CA843 employeesListed Aug 8, 2025heartflow.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology